CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer
DOI 10.1055/s-0040-1708342
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Derlin, R Werner, C Henkenberens, TL Ross, FM Bengel
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer
Zitieren
Zitierempfehlung
T Derlin, R Werner, C Henkenberens, TL Ross, FM Bengel (2020) Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708342
Mit CareLit weiterarbeiten